Drug recall · February 1, 2023
Advil (ibuprofen) Tablets recall
Why: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
- Lots / codes
a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025
- Quantity
- 321,246 tablets
- Company
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon, Warren, NJ
- Distribution
- Nationwide in the USA.
- Initiated
- December 6, 2022 · Voluntary: Firm initiated
- Classified
- January 25, 2023
- Reported
- February 1, 2023
- Ended
- February 26, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ibuprofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.